logo

For the Inventor, By the Inventor

Okayama, Japan

Hikaru Masahiro Watanabe

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: Hayashibara Co., Ltd., Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo. Active years: 2007-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hikaru Masahiro Watanabe. Retrieved from https://idiyas.com/inventor/hikaru-masahiro-watanabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 76.9

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal8 out of 47 
 
Hayashibara Co., Ltd.
 patents
silverMedal5 out of 375 
 
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
 patents

Years Active: 2007-2022

Loading Chart...
13 patents (USPTO):Explore Patents
1. 11330828 - Powdery plant extract for beverages and process for producing the same (2022-05-17),
2. 10076130 - Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses (2018-09-18),
3. 9528134 - Branched α-glucan, α-glucosyltransferase which forms the glucan, their preparation and uses (2016-12-27),
4. 9175282 - Cellobiose 2-epimerase, its preparation and uses (2015-11-03),
5. 9090923 - Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses (2015-07-28),
6. 8673608 - Branched α-glucan, α-glucosyltransferase which forms the glucan, their preparation and uses (2014-03-18),
7. 8633005 - Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses (2014-01-21),
8. 8324375 - Branched α-glucan, α-glucosyltransferase which forms the glucan, their preparation and uses (2012-12-04),
9. 7951530 - Cyclic maltosylmaltose, cyclic maltosymaltose-forming enzyme, their preparation and uses (2011-05-31),
10. 7732426 - Isocyclomaltooligosaccharide (S) , isocyclomaltooligosaccharide-forming enzyme, their preparation and uses (2010-06-08),
11. 7709230 - Process for producing isomaltose and uses thereof (2010-05-04),
12. 7309697 - Cyclic maltosylmatose (2007-12-18),
13. 7223570 - Branched cyclic tetrasaccharide, process for producing the same, and use (2007-05-29),

Title: The Innovative Journey of Hikaru Masahiro Watanabe

Introduction:

Hikaru Masahiro Watanabe, a visionary inventor hailing from Okayama, Japan, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Watanabe's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and sustainable materials. His innovative solutions have garnered international recognition for their potential to shape the future of various industries.

Career Highlights:

With a career spanning over two decades, Watanabe has established himself as a leading figure in the world of innovation. His relentless pursuit of excellence has led to the development of numerous patented technologies that have revolutionized the way we interact with the world around us.

Collaborations:

Throughout his career, Watanabe has collaborated with top research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines and borders has resulted in groundbreaking innovations that have set new standards in the industry.

Conclusion:

In conclusion, Hikaru Masahiro Watanabe's passion for innovation and his dedication to pushing the boundaries of what is possible have cemented his legacy as a pioneering inventor. His contributions continue to inspire future generations to think creatively and strive for excellence in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…